1201. Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?Tanja Marinko, Karmen Stanič, 2018, izvirni znanstveni članek Povzetek: Postmastectomy radiotherapy (PMRT) improves survival by eliminating potential occult lesions in the chest wall and lymphatic drainage area. Meta-analysis has shown that PMRT reduces mortality and local recurrence of patients with node positive breast cancer (but there is no specific data about the effectiveness of PMRT in a subgroup of patients with a high number of positive axillary lymph nodes (PALN). The aim of the study was to analyse the impact of the number of PALN on local and distant metastasis occurrence, overall survival (OS) and distant metastases free survival (DMFS) in patients treated with PMRT. Patients and methods. We reviewed medical records of 129 consecutive breast cancer patients with PALN, treated at Institute of Oncology Ljubljana with PMRT between January 2003 and December 2004. We grouped patients according to the number of PALN as follows: Group 1 (less than 15 PALN) and Group 2 with more than 15 PALN. All patients received adjuvant systemic therapy according to the clinical guidelines. We analysed number of locoregional (LR) recurrences, distant metastasis, overall survival, progression free survival (PFS) and DMFS. Results. After the median follow-up time of 11.5 years, the Kaplan-Meier survival analysis of PALN showed significantly shorter OS (p = 0.006), shorter PFS (p = 0.002) and shorter DMFS (p < 0.001) in the group of > 15 PALN. Only one LR was found in the group of patients with more than 15 PALN. In multivariate analysis more than 15 PALN and treatment with anthracycline chemotherapy statistically significantly influenced OS and DMFS. For PFS presence of more than 15 PALN were the only independent factor of shorter survival. Conclusions. Patients with more than 15 PALN have shorter DMFS, PFS and OS as compared to patients with less than 15 PALN, though they receive the same LR treatment. More studies with higher number of patients included are needed to further evaluate our findings. Ključne besede: radiotherapy, postmastectomy, axillary limph nodes, breast cancer Objavljeno v DiRROS: 10.06.2024; Ogledov: 208; Prenosov: 95
Celotno besedilo (300,04 KB) Gradivo ima več datotek! Več... |
1202. Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancerTanja Marinko, Simona Borštnar, Rok Blagus, Jure Dolenc, Cvetka Bilban-Jakopin, 2018, izvirni znanstveni članek Ključne besede: radiotherapy, adjuvant radiotherapy, cardiotoxicity, breast cancer Objavljeno v DiRROS: 10.06.2024; Ogledov: 196; Prenosov: 64
Celotno besedilo (300,87 KB) |
1203. |
1204. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapyMartina Vrankar, Karmen Stanič, 2018, izvirni znanstveni članek Povzetek: Standard treatment for patients with inoperable locally advanced non-small cell lung cancer (NSCLC) is concurrent chemoradiotherapy (CCRT). Five-year overall survival rates range between 15 and 25%, while long term survival data are rarely reported. Patients and methods A total of 102 patients with stage III NSCLC treated between September 2005 and November 2010 with induction chemotherapy and CCRT were included in this long term survival analysis. All patients were tested for PD-L1 status and expression of PD-L1 was correlated with overall survival (OS), progression free survival (PFS) and toxicities. Results The median OS of all patients was 24.8 months (95% CI 18.7 to 31.0) with 10 year-survival rate of 11.2%. The median OS of patients with PD-L1 expression was 12.1 months (95% CI 0.1 to 26.2), while in patients with negative or unknown PD-L1 status was significantly longer, 25.2 months (95% CI 18.9 to 31.6), p = 0.005. The median PFS of all patients was 16.4 months (95% CI 13.0 to 19.9). PFS of patients with PD-L1 expression was 10.1 months (95% CI 0.1 to 20.4) and in patients with negative or unknown PD-L1 status was 17.9 months (95% CI 14.2 to 21.7), p = 0.003. Conclusions 10-year overall survival of stage III NSCLC patients after CCRT is 11.2%. PFS and OS differ with regard to PD-L1 status and are significantly shorter for patients with PD-L1 expression. New treatment with check-point inhibitors combined with RT therefore seems reasonable strategy to improve these results. Ključne besede: NSCLC, non-small cell lung cancer, locally advanced, immunotherapy, chemoradiotherapy Objavljeno v DiRROS: 10.06.2024; Ogledov: 211; Prenosov: 113
Celotno besedilo (500,20 KB) Gradivo ima več datotek! Več... |
1205. The influence of genetic variability on the risk of developing malignant mesotheliomaAlenka Franko, Nika Kotnik, Katja Goričar, Viljem Kovač, Metoda Dodič-Fikfak, Vita Dolžan, 2018, izvirni znanstveni članek Ključne besede: malignant mesothelioma, genetic polymorphism, antioxidative enzymes, genetic variability Objavljeno v DiRROS: 10.06.2024; Ogledov: 222; Prenosov: 83
Celotno besedilo (1,13 MB) |
1206. |
1207. |
1208. |
1209. |
1210. First report on the uppermost Permian ostracods from the Masore section (External Dinarides), SloveniaTea Kolar-Jurkovšek, Ewa Olempska, Bogdan Jurkovšek, 2024, izvirni znanstveni članek Povzetek: The ostracod assemblages from the Upper Permian and Permian-Triassic transitional strata of the Masore section in the External Dinarides (Slovenia) were studied. Altogether 13 genera and 20 species of the orders Palaeocopida, Platycopida and Podocopida are identified and illustrated. All recovered ostracods belong to shallow marine taxa. The older fauna from the uppermost Permian and the younger fauna from the Permian-Triassic boundary strata are distinguished. The obtained fauna from the Permian Bellerophon Formation corresponds to the “benthonic ostracod Eifelian Mega-assemblage” occupying the shelf sea floors. This study presents the first report of ostracod faunas from the uppermost Permian and Permian-Triassic boundary interval of Slovenia. The recovered ostracod fauna display a distinct faunal change and yield important paleobiogeographic implications as it reveals similarity with stratigraphical equivalent faunas from some other neighboring localities in the western Paleotethys, such as Bulla in Italy, Komirić in Serbia, and the Bükk Mountains in Hungary. Ključne besede: microfauna, Changhsingian, Permian-Triassic boundary strata, Dinarides Objavljeno v DiRROS: 10.06.2024; Ogledov: 205; Prenosov: 101
Celotno besedilo (4,06 MB) |